| Market Cap | ₹2,382Cr |
| ROE | 9.16% |
| P/E Ratio(TTM) | 28.17 |
| EPS(TTM) | 26.07 |
| P/B Ratio | 2.58 |
| Dividend Yield | 0.37% |
| Industry P/E | 60.21 |
| Book Value | 284.52 |
| Debt to Equity | 0.31 |
| Face Value | 5 |
| Parent Organisation | Krsnaa Diagnostics |
| Managing Director | Ms. Pallavi Bhatevara |
| Founded | 2010 |
| NSE Symbol | KRSNAA |
| FUND NAME | AUM(%) |
|---|---|
| Tata Small Cap Fund Direct Growth | 1.83% |
| Bandhan Small Cap Fund Direct Growth | 0.26% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 44.59 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 66.92 | ||
| Metropolis Healthcare | NA (0.00%) | 62.31 | ||
| Thyrocare Technologies | NA (0.00%) | 54.60 |